Vor Biopharma Inc.

NASDAQ:VOR

Biotechnology

Healthcare
$18.52 -2.26%

-$0.34 today

Market cap
$1.00B
Beta
1.73
P/E (TTM)
-0.0
EPS (TTM)
-$2,053.13
52W Low $4.28High $65.80

Volume 0.83M

Average 1.07M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$371.64M

FY 2025 · Annual

Net Income

-$695.98M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue08.96M3.49M00
Gross Profit0(8.96M)(3.49M)00
Gross Margin—————
Research & Development47.53M64.55M94.32M93.31M321.53M
Selling, General & Admin21.49M19.91M31.72M27.88M50.11M
Operating Expenses69.02M84.46M122.54M121.19M371.64M
Depreciation & Amortization1.43M8.96M3.49M3.53M2.89M
EBITDA(67.47M)(83.13M)(114.37M)(113.39M)(693.09M)
EBITDA Margin—————
Operating Income(69.02M)(93.42M)(126.04M)(121.19M)(371.64M)
Operating Margin—————
Interest Income119K1.32M8.17M4.27M5.87M
Interest Expense00000
Other Income / Expenses119K1.32M8.17M4.27M(324.34M)
Income Before Tax(68.9M)(92.09M)(117.86M)(116.91M)(695.98M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(68.9M)(92.09M)(117.86M)(116.91M)(695.98M)
Net Margin—————
EPS (Basic)(37.80)(46.60)(35.00)(34.00)(70.50)
EPS (Diluted)(37.80)(46.60)(35.00)(34.00)(70.50)
Weighted Avg Shares1.86M1.98M3.36M3.44M9.87M
Weighted Avg Shares (Diluted)1.86M1.98M3.36M3.44M9.87M

VOR Earnings Waterfall · TTM

NASDAQ:VOR · Revenue to Net Income

Key Ratios

EPS$-838.86
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$883.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-838.86, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
424B5424B5 filingOct 30, 2026
10-QQuarterly reportOct 30, 2026

How much revenue does VOR generate?

Vor Biopharma Inc. (VOR) reported $0.00 of revenue in fiscal 2025.

Is VOR profitable?

Vor Biopharma Inc. (VOR) reported -$695.98M of net income.